source name	characteristics[organism]	characteristics[organism part]	characteristics[individual]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	comment[biological replicate]	characteristics[sampling time]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[fractionation method]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[proteomics data adquisition method]	comment[instrument]	comment[separation]	comment[modification parameter]	comment[modification parameter]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	value[organism part]
PXD012667-Sample-1	Homo sapiens	blood plasma	1	not applicable	not available	69	Male	not available	Type 2 Diabetes Mellitus	no depletion	1	not applicable	171031_TTSH_Disease1_A1	proteomic profiling by mass spectrometry	171031_TTSH_Disease1_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease1_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-2	Homo sapiens	blood plasma	1	not applicable	not available	69	Male	not available	Type 2 Diabetes Mellitus	no depletion	1	not applicable	171031_TTSH_Disease1_B1	proteomic profiling by mass spectrometry	171031_TTSH_Disease1_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease1_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-3	Homo sapiens	blood plasma	1	not applicable	not available	69	Male	not available	Type 2 Diabetes Mellitus	no depletion	1	not applicable	171031_TTSH_Disease1_C1	proteomic profiling by mass spectrometry	171031_TTSH_Disease1_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease1_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-4	Homo sapiens	blood plasma	2	not applicable	not available	67	Male	not available	Type 2 Diabetes Mellitus	no depletion	2	not applicable	171031_TTSH_Disease2_A1	proteomic profiling by mass spectrometry	171031_TTSH_Disease2_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease2_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-5	Homo sapiens	blood plasma	2	not applicable	not available	67	Male	not available	Type 2 Diabetes Mellitus	no depletion	2	not applicable	171031_TTSH_Disease2_B1	proteomic profiling by mass spectrometry	171031_TTSH_Disease2_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease2_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-6	Homo sapiens	blood plasma	2	not applicable	not available	67	Male	not available	Type 2 Diabetes Mellitus	no depletion	2	not applicable	171031_TTSH_Disease2_C1	proteomic profiling by mass spectrometry	171031_TTSH_Disease2_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease2_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-7	Homo sapiens	blood plasma	3	not applicable	not available	65	Male	not available	Type 2 Diabetes Mellitus	no depletion	3	not applicable	171031_TTSH_Disease3_A1	proteomic profiling by mass spectrometry	171031_TTSH_Disease3_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease3_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-8	Homo sapiens	blood plasma	3	not applicable	not available	65	Male	not available	Type 2 Diabetes Mellitus	no depletion	3	not applicable	171031_TTSH_Disease3_B1	proteomic profiling by mass spectrometry	171031_TTSH_Disease3_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease3_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-9	Homo sapiens	blood plasma	3	not applicable	not available	65	Male	not available	Type 2 Diabetes Mellitus	no depletion	3	not applicable	171031_TTSH_Disease3_C1	proteomic profiling by mass spectrometry	171031_TTSH_Disease3_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease3_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-10	Homo sapiens	blood plasma	4	not applicable	not available	59	Male	not available	Type 2 Diabetes Mellitus	no depletion	4	not applicable	171031_TTSH_Disease4_A1	proteomic profiling by mass spectrometry	171031_TTSH_Disease4_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease4_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-11	Homo sapiens	blood plasma	4	not applicable	not available	59	Male	not available	Type 2 Diabetes Mellitus	no depletion	4	not applicable	171031_TTSH_Disease4_B1	proteomic profiling by mass spectrometry	171031_TTSH_Disease4_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease4_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-12	Homo sapiens	blood plasma	4	not applicable	not available	59	Male	not available	Type 2 Diabetes Mellitus	no depletion	4	not applicable	171031_TTSH_Disease4_C1	proteomic profiling by mass spectrometry	171031_TTSH_Disease4_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease4_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-13	Homo sapiens	blood plasma	5	not applicable	not available	59	Male	not available	Type 2 Diabetes Mellitus	no depletion	5	not applicable	171031_TTSH_Disease5_A1	proteomic profiling by mass spectrometry	171031_TTSH_Disease5_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease5_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-14	Homo sapiens	blood plasma	5	not applicable	not available	59	Male	not available	Type 2 Diabetes Mellitus	no depletion	5	not applicable	171031_TTSH_Disease5_B1	proteomic profiling by mass spectrometry	171031_TTSH_Disease5_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease5_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-15	Homo sapiens	blood plasma	5	not applicable	not available	59	Male	not available	Type 2 Diabetes Mellitus	no depletion	5	not applicable	171031_TTSH_Disease5_C1	proteomic profiling by mass spectrometry	171031_TTSH_Disease5_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease5_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-16	Homo sapiens	blood plasma	6	not applicable	not available	67	Male	not available	Type 2 Diabetes Mellitus	no depletion	6	not applicable	171031_TTSH_Disease6_A1	proteomic profiling by mass spectrometry	171031_TTSH_Disease6_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease6_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-17	Homo sapiens	blood plasma	6	not applicable	not available	67	Male	not available	Type 2 Diabetes Mellitus	no depletion	6	not applicable	171031_TTSH_Disease6_B1	proteomic profiling by mass spectrometry	171031_TTSH_Disease6_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease6_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-18	Homo sapiens	blood plasma	6	not applicable	not available	67	Male	not available	Type 2 Diabetes Mellitus	no depletion	6	not applicable	171031_TTSH_Disease6_C1	proteomic profiling by mass spectrometry	171031_TTSH_Disease6_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease6_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-19	Homo sapiens	blood plasma	7	not applicable	not available	52	Male	not available	Type 2 Diabetes Mellitus	no depletion	7	not applicable	171031_TTSH_Disease7_A1	proteomic profiling by mass spectrometry	171031_TTSH_Disease7_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease7_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-20	Homo sapiens	blood plasma	7	not applicable	not available	52	Female	not available	Type 2 Diabetes Mellitus	no depletion	7	not applicable	171031_TTSH_Disease7_B1	proteomic profiling by mass spectrometry	171031_TTSH_Disease7_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease7_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-21	Homo sapiens	blood plasma	7	not applicable	not available	52	Female	not available	Type 2 Diabetes Mellitus	no depletion	7	not applicable	171031_TTSH_Disease7_C1	proteomic profiling by mass spectrometry	171031_TTSH_Disease7_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease7_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-22	Homo sapiens	blood plasma	8	not applicable	not available	72	Female	not available	Type 2 Diabetes Mellitus	no depletion	8	not applicable	171031_TTSH_Disease8_A1	proteomic profiling by mass spectrometry	171031_TTSH_Disease8_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease8_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-23	Homo sapiens	blood plasma	8	not applicable	not available	72	Male	not available	Type 2 Diabetes Mellitus	no depletion	8	not applicable	171031_TTSH_Disease8_B1	proteomic profiling by mass spectrometry	171031_TTSH_Disease8_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease8_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-24	Homo sapiens	blood plasma	8	not applicable	not available	72	Male	not available	Type 2 Diabetes Mellitus	no depletion	8	not applicable	171031_TTSH_Disease8_C1	proteomic profiling by mass spectrometry	171031_TTSH_Disease8_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Disease8_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-25	Homo sapiens	blood plasma	9	not applicable	not available	54	Male	not available	Normal	no depletion	9	not applicable	171031_TTSH_Healthy1_A1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy1_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy1_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-26	Homo sapiens	blood plasma	9	not applicable	not available	54	Male	not available	Normal	no depletion	9	not applicable	171031_TTSH_Healthy1_B1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy1_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy1_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-27	Homo sapiens	blood plasma	9	not applicable	not available	54	Male	not available	Normal	no depletion	9	not applicable	171031_TTSH_Healthy1_C1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy1_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy1_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-28	Homo sapiens	blood plasma	10	not applicable	not available	53	Male	not available	Normal	no depletion	10	not applicable	171031_TTSH_Healthy2_A1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy2_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy2_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-29	Homo sapiens	blood plasma	10	not applicable	not available	53	Male	not available	Normal	no depletion	10	not applicable	171031_TTSH_Healthy2_B1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy2_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy2_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-30	Homo sapiens	blood plasma	10	not applicable	not available	53	Male	not available	Normal	no depletion	10	not applicable	171031_TTSH_Healthy2_C1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy2_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy2_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-31	Homo sapiens	blood plasma	11	not applicable	not available	56	Male	not available	Normal	no depletion	11	not applicable	171031_TTSH_Healthy3_A1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy3_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy3_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-32	Homo sapiens	blood plasma	11	not applicable	not available	56	Male	not available	Normal	no depletion	11	not applicable	171031_TTSH_Healthy3_B1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy3_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy3_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-33	Homo sapiens	blood plasma	11	not applicable	not available	56	Male	not available	Normal	no depletion	11	not applicable	171031_TTSH_Healthy3_C1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy3_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy3_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-34	Homo sapiens	blood plasma	12	not applicable	not available	53	Male	not available	Normal	no depletion	12	not applicable	171031_TTSH_Healthy4_A1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy4_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy4_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-35	Homo sapiens	blood plasma	12	not applicable	not available	53	Male	not available	Normal	no depletion	12	not applicable	171031_TTSH_Healthy4_B1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy4_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy4_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-36	Homo sapiens	blood plasma	12	not applicable	not available	53	Male	not available	Normal	no depletion	12	not applicable	171031_TTSH_Healthy4_C1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy4_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy4_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-37	Homo sapiens	blood plasma	13	not applicable	not available	55	Male	not available	Normal	no depletion	13	not applicable	171031_TTSH_Healthy5_A1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy5_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy5_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-38	Homo sapiens	blood plasma	13	not applicable	not available	55	Male	not available	Normal	no depletion	13	not applicable	171031_TTSH_Healthy5_B1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy5_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy5_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-39	Homo sapiens	blood plasma	13	not applicable	not available	55	Male	not available	Normal	no depletion	13	not applicable	171031_TTSH_Healthy5_C1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy5_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy5_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-40	Homo sapiens	blood plasma	14	not applicable	not available	68	Female	not available	Normal	no depletion	14	not applicable	171031_TTSH_Healthy6_A1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy6_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy6_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-41	Homo sapiens	blood plasma	14	not applicable	not available	68	Female	not available	Normal	no depletion	14	not applicable	171031_TTSH_Healthy6_B1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy6_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy6_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-42	Homo sapiens	blood plasma	14	not applicable	not available	68	Female	not available	Normal	no depletion	14	not applicable	171031_TTSH_Healthy6_C1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy6_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy6_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-43	Homo sapiens	blood plasma	15	not applicable	not available	55	Male	not available	Normal	no depletion	15	not applicable	171031_TTSH_Healthy7_A1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy7_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy7_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-44	Homo sapiens	blood plasma	15	not applicable	not available	55	Male	not available	Normal	no depletion	15	not applicable	171031_TTSH_Healthy7_B1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy7_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy7_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-45	Homo sapiens	blood plasma	15	not applicable	not available	55	Male	not available	Normal	no depletion	15	not applicable	171031_TTSH_Healthy7_C1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy7_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy7_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-46	Homo sapiens	blood plasma	16	not applicable	not available	50	Male	not available	Normal	no depletion	16	not applicable	171031_TTSH_Healthy8_A1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy8_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy8_A1.raw	1	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-47	Homo sapiens	blood plasma	16	not applicable	not available	50	Male	not available	Normal	no depletion	16	not applicable	171031_TTSH_Healthy8_B1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy8_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy8_B1.raw	2	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
PXD012667-Sample-48	Homo sapiens	blood plasma	16	not applicable	not available	50	Male	not available	Normal	no depletion	16	not applicable	171031_TTSH_Healthy8_C1	proteomic profiling by mass spectrometry	171031_TTSH_Healthy8_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD012667/171031_TTSH_Healthy8_C1.raw	3	AC=PRID:0000555; NT=ERLIC	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=PRIDE:0000627; NT=Data-dependent adquisition	AC=MS:1001911 ; NT=Q Exactive	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Tryoxidation;AC=UNIMOD:345 ;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	28 NCE	10 ppm 	30 ppm	blood plasma
